Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingwang Zhang

Showing results (251-260 of 256) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 256 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2021
CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaYongxian Hu, Yali Zhou, Mingming Zhang, et al.
Angewandte Chemie (International Ed. in English)|September 9, 2021
Biosynthesis of Chuangxinmycin Featuring a Deubiquitinase-like SulfurtransferaseXingwang Zhang, Xiaokun Xu, Cai You, et al.
Microbial Cell Factories|October 10, 2022
Diversification of phenolic glucosides by two UDP-glucosyltransferases featuring complementary regioselectivityFei Guo, Xingwang Zhang, Cai You, et al.
Journal of the American Chemical Society|June 20, 2025
Deciphering the Thiolactonization Mechanism in Thiolactomycin BiosynthesisJiawei Guo, Qiaoyu Zhang, Yang Shen, et al.
Nature Catalysis|September 14, 2020
Fungal-derived brevianamide assembly by a stereoselective semipinacolaseYing Ye, Lei Du, Xingwang Zhang, et al.
Cell Research|September 23, 2022
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical studyYongxian Hu, Yali Zhou, Mingming Zhang, et al.
Pageof 26

Showing results (251-260 of 256) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 256 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2021
CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaYongxian Hu, Yali Zhou, Mingming Zhang, et al.
Angewandte Chemie (International Ed. in English)|September 9, 2021
Biosynthesis of Chuangxinmycin Featuring a Deubiquitinase-like SulfurtransferaseXingwang Zhang, Xiaokun Xu, Cai You, et al.
Microbial Cell Factories|October 10, 2022
Diversification of phenolic glucosides by two UDP-glucosyltransferases featuring complementary regioselectivityFei Guo, Xingwang Zhang, Cai You, et al.
Journal of the American Chemical Society|June 20, 2025
Deciphering the Thiolactonization Mechanism in Thiolactomycin BiosynthesisJiawei Guo, Qiaoyu Zhang, Yang Shen, et al.
Nature Catalysis|September 14, 2020
Fungal-derived brevianamide assembly by a stereoselective semipinacolaseYing Ye, Lei Du, Xingwang Zhang, et al.
Cell Research|September 23, 2022
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical studyYongxian Hu, Yali Zhou, Mingming Zhang, et al.
Pageof 26